HONG KONG and SHANGHAI and FLORHAM PARK, N.J., Aug. 20, 2025 (GLOBE NEWSWIRE) — HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM:​HCM; HKEX:​13) today announces the completion of patient enrollment of SANOVO, a China Phase III study of ORPATHYS® (savolitinib) and TAGRISSO® (osimertinib) as a first-line treatment in certain non-small cell lung cancer (“NSCLC”) patients whose tumors harbor epidermal growth factor receptor (“EGFR”) mutation and MET overexpression. The last patient was enrolled on August 18, 2025. This Phase III trial is a blinded, randomized, controlled study in previously untreated patients with locally advanced or metastatic NSCLC with activating EGFR mutations and MET overexpression. The study will evaluate the efficacy and safety of TAGRISSO® in combination with ORPATHYS® comparing to TAGRISSO® alone, a standard-of-care...

Dallas, TX, Aug. 19, 2025 (GLOBE NEWSWIRE) — Vivakor, Inc. (Nasdaq: VIVK) (“Vivakor” or the “Company”), an integrated provider of energy transportation, storage, reuse, and remediation services, today announced it would reset the record date of the previously-announced special dividend to Vivakor shareholders from August 20, 2025 to September 5, 2025. Vivakor currently holds 206,595 (approximately 13.5% of the outstanding common) shares of Adapti, Inc., a company set to merge with a multi-platform sports agency representing amateuer and professional athletes at all levels that they intend to integrate withtheir pre-existing AdaptAI software platform that matches products with influencers to market athletic careers and associated branding opportunities. Based on Vivakor’s current shares outstanding of approximately 47,297,347 and...

Investment to support NovaBay’s continued public listing and provide funding for a future strategic transaction EMERYVILLE, Calif., Aug. 19, 2025 (GLOBE NEWSWIRE) — NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY) (“NovaBay” or the “Company”) announces it has entered into a $6 million securities purchase agreement with private investor David E. Lazar for the purchase of the Company’s non-voting convertible preferred stock. NovaBay has received $3.85 million in the first of two closings under the agreement. Effective immediately, Mr. Lazar has been appointed NovaBay’s Chief Executive Officer and a director of the Company. Former Chief Executive Officer Justin Hall has assumed the newly created position of Vice President of Business Development. At NovaBay’s Special Meeting on April 16, 2025, stockholders authorized the Company’s...

YUBA CITY, Calif., Aug. 19, 2025 (GLOBE NEWSWIRE) — River Valley Community Bancorp (OTC Markets: RVCB) is excited to announce the addition of key banking professionals to its Yuba Sutter market, significantly expanding the bank’s ability to serve the agricultural community and small businesses throughout the region. The enhanced team brings decades of commercial and agricultural lending experience, marking a commitment to supporting local farmers and agribusiness. Leading this expansion is Matt Peyret, who joins as Senior Vice President and Market Manager for the Yuba Sutter market. With over 20 years of commercial and agricultural banking experience in the Greater Sacramento region, Matt brings deep expertise in credit structuring, risk management, and team leadership specifically tailored to the unique needs of agricultural...